6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          To provide multi-national, multi-ethnic data on the clinical characteristics and prognosis of patients with microvascular angina (MVA).

          Methods and results

          The Coronary Vasomotor Disorders International Study Group proposed the diagnostic criteria for MVA. We prospectively evaluated the clinical characteristics of patients according to these criteria and their prognosis. The primary endpoint was the composite of major cardiovascular events (MACE), verified by institutional investigators, which included cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and hospitalization due to heart failure or unstable angina. During the period from 1 July 2015 to 31 December 2018, 686 patients with MVA were registered from 14 institutes in 7 countries from 4 continents. Among them, 64% were female and the main ethnic groups were Caucasians (61%) and Asians (29%). During follow-up of a median of 398 days (IQR 365–744), 78 MACE occurred (6.4% in men vs. 8.6% in women, P = 0.19). Multivariable Cox proportional hazard analysis disclosed that hypertension and previous history of coronary artery disease (CAD), including acute coronary syndrome and stable angina pectoris, were independent predictors of MACE. There was no sex or ethnic difference in prognosis, although women had lower Seattle Angina Questionnaire scores than men ( P < 0.05).

          Conclusions

          This first international study provides novel evidence that MVA is an important health problem regardless of sex or ethnicity that a diagnosis of MVA portends a substantial risk for MACE associated with hypertension and previous history of CAD, and that women have a lower quality of life than men despite the comparable prognosis.

          Graphical Abstract

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

          Background and Purpose- The purpose of these guidelines is to provide an up-to-date comprehensive set of recommendations in a single document for clinicians caring for adult patients with acute arterial ischemic stroke. The intended audiences are prehospital care providers, physicians, allied health professionals, and hospital administrators. These guidelines supersede the 2013 Acute Ischemic Stroke (AIS) Guidelines and are an update of the 2018 AIS Guidelines. Methods- Members of the writing group were appointed by the American Heart Association (AHA) Stroke Council's Scientific Statements Oversight Committee, representing various areas of medical expertise. Members were not allowed to participate in discussions or to vote on topics relevant to their relations with industry. An update of the 2013 AIS Guidelines was originally published in January 2018. This guideline was approved by the AHA Science Advisory and Coordinating Committee and the AHA Executive Committee. In April 2018, a revision to these guidelines, deleting some recommendations, was published online by the AHA. The writing group was asked review the original document and revise if appropriate. In June 2018, the writing group submitted a document with minor changes and with inclusion of important newly published randomized controlled trials with >100 participants and clinical outcomes at least 90 days after AIS. The document was sent to 14 peer reviewers. The writing group evaluated the peer reviewers' comments and revised when appropriate. The current final document was approved by all members of the writing group except when relationships with industry precluded members from voting and by the governing bodies of the AHA. These guidelines use the American College of Cardiology/AHA 2015 Class of Recommendations and Level of Evidence and the new AHA guidelines format. Results- These guidelines detail prehospital care, urgent and emergency evaluation and treatment with intravenous and intra-arterial therapies, and in-hospital management, including secondary prevention measures that are appropriately instituted within the first 2 weeks. The guidelines support the overarching concept of stroke systems of care in both the prehospital and hospital settings. Conclusions- These guidelines provide general recommendations based on the currently available evidence to guide clinicians caring for adult patients with acute arterial ischemic stroke. In many instances, however, only limited data exist demonstrating the urgent need for continued research on treatment of acute ischemic stroke.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            OUP accepted manuscript

            (2020)
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Third universal definition of myocardial infarction.

                Bookmark

                Author and article information

                Journal
                Eur Heart J
                Eur Heart J
                eurheartj
                European Heart Journal
                Oxford University Press
                0195-668X
                1522-9645
                21 November 2021
                26 May 2021
                26 May 2021
                : 42
                : 44 , Focus Issue on Epidemiology and Prevention
                : 4592-4600
                Affiliations
                [1 ] Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Sendai, Japan
                [2 ] International University of Health and Welfare , Narita, Japan
                [3 ] British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow , UK
                [4 ] Vita Salute University and San Raffaele Hospital , Milan, Italy
                [5 ] Department of Cardiology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore , Rome, Italy
                [6 ] Department of Cardiology, Hospital Clínico San Carlos IDISSC and Universidad Complutense de Madrid , Madrid, Spain
                [7 ] Department of Cardiovascular Science, Cardiovascular and Cell Sciences Res Institute, St George’s, University of London , UK
                [8 ] Department of Cardiology, Tokai University Oiso Hospital , Oiso, Japan
                [9 ] Department of Medicine, Division of Cardiology, Emory University , Atlanta, GA, USA
                [10 ] Department of Cardiology, Robert-Bosch-Krankenhaus , Stuttgart, Germany
                [11 ] Department of Cardiology, Fujita Health University School of Medicine , Toyonaka, Aichi, Japan
                [12 ] Division of Cardiovascular Medicine, University of Florida, College of Medicine , Gainesville, FL, USA
                [13 ] Institute of Molecular Bioimaging and Physiology, Consiglio Nazionale delle Ricerche , Segrate, Italy
                [14 ] Department of Emergency Medicine, Yale University , New Haven, CT, USA
                [15 ] Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University , Kumamoto, Japan
                [16 ] The Discipline of Medicine, University of Adelaide, Basil Hetzel Institute, Central Adelaide Local Health Network , Adelaide, South Australia, Australia
                [17 ] Department of Cardiology, Cedars-Sinai Medical Center, Barbra Streisand Women's Heart Center, Smidt Heart Institute , Los Angeles, CA, USA
                Author notes
                Corresponding author. Tel: +81-22-717-7153, Fax: +81-22-717-7153, Email: shimo@ 123456cardio.med.tohoku.ac.jp
                Author information
                https://orcid.org/0000-0002-4547-8636
                https://orcid.org/0000-0001-5584-0750
                https://orcid.org/0000-0002-9482-411X
                https://orcid.org/0000-0003-4932-0112
                https://orcid.org/0000-0003-4009-6652
                https://orcid.org/0000-0002-2962-6141
                https://orcid.org/0000-0001-8068-0189
                https://orcid.org/0000-0002-5678-812X
                https://orcid.org/0000-0003-2253-2828
                https://orcid.org/0000-0002-6011-681X
                https://orcid.org/0000-0002-7091-1235
                https://orcid.org/0000-0002-9640-7133
                https://orcid.org/0000-0003-4549-9901
                https://orcid.org/0000-0002-7470-5236
                https://orcid.org/0000-0002-4294-6510
                Article
                ehab282
                10.1093/eurheartj/ehab282
                8633728
                34038937
                9f0f729d-4de2-4438-932a-521d1b55c85b
                © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 14 January 2021
                : 01 March 2021
                : 23 April 2021
                : 22 April 2021
                : 20 November 2021
                Page count
                Pages: 9
                Funding
                Funded by: The Japanese Coronary Spasm Association;
                Funded by: Japan Heart Foundation, DOI 10.13039/501100013642;
                Funded by: The British Heart Foundation;
                Award ID: PG/17/2532884
                Award ID: RE/18/6134217
                Funded by: The National Heart, Lung and Blood Institutes;
                Award ID: N01-HV-68161
                Award ID: N01-HV-68162
                Award ID: N01-HV-68163
                Award ID: N01-HV-68164
                Award ID: U0164829
                Award ID: U01 HL649141
                Award ID: U01 HL649241
                Award ID: K23HL105787
                Award ID: T32HL69751
                Award ID: R01 HL090957
                Award ID: 1R03AG032631
                Funded by: National Institute on Aging, DOI 10.13039/100000049;
                Award ID: MO1-RR00425
                Funded by: National Center for Research Resources, DOI 10.13039/100000097;
                Funded by: National Center for Advancing Translational Sciences, DOI 10.13039/100006108;
                Award ID: UL1TR000124
                Award ID: UL1TR000064
                Categories
                Clinical Research
                Epidemiology and Prevention
                Editor's Choice
                AcademicSubjects/MED00200

                Cardiovascular Medicine
                microvascular angina,coronary microvascular dysfunction,prognosis
                Cardiovascular Medicine
                microvascular angina, coronary microvascular dysfunction, prognosis

                Comments

                Comment on this article